Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Switzerland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20141
20151
20161
20173
20181
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Adherex Technologies, Inc.1
Amgen1
Bristol-Myers Squibb1
CureVac1
Eli Lilly and Company1
Hoffmann-La Roche1
Immunophotonics, Inc.1
Incyte Biosciences International Sàrl1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung14
Melanoma3
Neoplasms3
Carcinoma, Renal Cell2
Colonic Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Bronchial Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.